BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1707418)

  • 1. Recovery of CD3+ and CD5- lymphocyte subpopulation after autologous bone marrow transplantation and chemotherapy.
    McKay PJ; McLaren A; Andrews LM; Lucie NP
    J Clin Pathol; 1991 Mar; 44(3):259-61. PubMed ID: 1707418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5-T lymphocytes in renal transplant recipients.
    McKay PJ; Kyle B; McLaren A; McMillan MA; Lucie NP
    Clin Lab Haematol; 1991; 13(4):335-40. PubMed ID: 1723035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive T lymphocytes.
    Spour EF; Leemhuis T; Jenski L; Redmond R; Fillak D; Jansen J
    Clin Exp Immunol; 1990 Apr; 80(1):114-21. PubMed ID: 1691061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation.
    Bierer BE; Burakoff SJ; Smith BR
    Blood; 1989 Apr; 73(5):1359-66. PubMed ID: 2467708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mlsa generated suppressor cells. I. Suppression is mediated by double-negative (CD3+CD5+CD4-CD8-) alpha/beta T cell receptor-bearing cells.
    Bruley-Rosset M; Miconnet I; Canon C; Halle-Pannenko O
    J Immunol; 1990 Dec; 145(12):4046-52. PubMed ID: 1701781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia.
    Uckun FM; Ramsay NK; Waddick KG; Jaszcz W; Chandan-Langlie M; Obuz V; Haake R; Gajl-Peczalska K; Kersey JH; Song CW
    Blood; 1991 Dec; 78(11):2945-55. PubMed ID: 1835411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow.
    Drobyski WR; Piaskowski V; Ash RC; Casper JT; Truitt RL
    Transplantation; 1990 Oct; 50(4):625-32. PubMed ID: 1699309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and function of CD3 and CD5 in patients with primary Sjögren's syndrome.
    Dauphinée MJ; Tovar Z; Ballester A; Talal N
    Arthritis Rheum; 1989 Apr; 32(4):420-9. PubMed ID: 2468337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.
    Soiffer RJ; Bosserman L; Murray C; Cochran K; Daley J; Ritz J
    Blood; 1990 May; 75(10):2076-84. PubMed ID: 1970938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.
    Sakamoto H; Michaelson J; Jones WK; Bhan AK; Abhyankar S; Silverstein M; Golan DE; Burakoff SJ; Ferrara JL
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10890-4. PubMed ID: 1835792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation.
    Okunewick JP; Kociban DL; Machen LL; Buffo MJ
    Bone Marrow Transplant; 1994 Jan; 13(1):11-7. PubMed ID: 7517254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8- cell population.
    Abraham VS; Sachs DH; Sykes M
    J Immunol; 1992 Jun; 148(12):3746-52. PubMed ID: 1534824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of early graft-versus-host disease--a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients.
    Sviland L; Pearson AD; Green MA; Baker BD; Eastham EJ; Reid MM; Hamilton PJ; Proctor SJ; Malcolm AJ
    Transplantation; 1991 Dec; 52(6):1029-36. PubMed ID: 1836284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
    Przepiorka D; Chan KW; Champlin RE; Culbert SJ; Petropoulos D; Ippoliti C; Khouri I; Huh YO; Vreisendorp H; Deisseroth AB
    Bone Marrow Transplant; 1995 Dec; 16(6):737-41. PubMed ID: 8750262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
    Soiffer RJ; Weller E; Alyea EP; Mauch P; Webb IL; Fisher DC; Freedman AS; Schlossman RL; Gribben J; Lee S; Anderson KC; Marcus K; Stone RM; Antin JH; Ritz J
    J Clin Oncol; 2001 Feb; 19(4):1152-9. PubMed ID: 11181681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5-positive B cells after T cell depleted bone marrow transplantation.
    Drexler HG; Brenner MK; Wimperis JZ; Gignac SM; Janossy G; Prentice HG; Hoffbrand AV
    Clin Exp Immunol; 1987 Jun; 68(3):662-8. PubMed ID: 3308220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.
    Lowdell MW; Craston R; Ray N; Koh M; Galatowicz G; Prentice HG
    Bone Marrow Transplant; 1998 Apr; 21(7):679-86. PubMed ID: 9578307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.